Panvascular concept in the evaluation and treatment of intracranial atherosclerotic stenosis
- PMID: 39777318
- PMCID: PMC11704892
- DOI: 10.3389/fneur.2024.1460124
Panvascular concept in the evaluation and treatment of intracranial atherosclerotic stenosis
Abstract
Cerebrovascular disease is the leading causes of death and disability worldwide. Intracranial atherosclerotic stenosis (ICAS) is one of the major causes of ischemic stroke, especially in the Asian population. It is urgent to explore effective screening methods for early diagnosis to improve prognosis of patients with ICAS. Recently, the concept of panvascular medicine has provided a direction for the exploration of evaluation of ICAS. Based on the concept of "panvascular medicine," atherosclerosis is the common pathological feature of panvascular disease, such as ICAS and coronary artery disease (CAD). In-depth research on the formation and development of plaques, the development and application of more precise preoperative assessment and detection methods, and the utilization of new interventional equipment have greatly enhanced the precision of diagnosis and treatment of CAD. Studies attempt to apply similar evaluation and treatment in ICAS. The deeper understanding, the more accurate diagnosis and treatment, contributing to improve the prognosis of patients with ICAS. This review focuses on these evaluations and treatment of CAD applied in the field of ICAS.
Keywords: coronary artery disease; fractional flow reserve; intracranial atherosclerotic stenosis; panvascular medicine; plaque.
Copyright © 2024 Tang, Zhou, Lu, Shi, Cheng, Xiang, Wan and Wang.
Conflict of interest statement
JX was employed by ArteryFlow Technology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Intracranial Atherosclerotic Stenosis.Cerebrovasc Dis Extra. 2025;15(1):62-67. doi: 10.1159/000543356. Epub 2025 Jan 2. Cerebrovasc Dis Extra. 2025. PMID: 39746334 Free PMC article. Review.
-
Quantitative assessment of symptomatic intracranial atherosclerosis and lenticulostriate arteries in recent stroke patients using whole-brain high-resolution cardiovascular magnetic resonance imaging.J Cardiovasc Magn Reson. 2018 Jun 7;20(1):35. doi: 10.1186/s12968-018-0465-8. J Cardiovasc Magn Reson. 2018. PMID: 29880054 Free PMC article.
-
Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort study.Ann Transl Med. 2022 Aug;10(16):909. doi: 10.21037/atm-22-3570. Ann Transl Med. 2022. PMID: 36111049 Free PMC article.
-
Correlation of Plasma Vascular Endothelial Growth Factor and Endostatin Levels with Symptomatic Intra- and Extracranial Atherosclerotic Stenosis in a Chinese Han Population.J Stroke Cerebrovasc Dis. 2017 May;26(5):1061-1070. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.021. Epub 2017 Feb 8. J Stroke Cerebrovasc Dis. 2017. PMID: 28189572
-
Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions.Brain Behav. 2016 Aug 31;6(11):e00536. doi: 10.1002/brb3.536. eCollection 2016 Nov. Brain Behav. 2016. PMID: 27843693 Free PMC article. Review.
References
-
- Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, et al. . Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. (2015) 313:1240–8. doi: 10.1001/jama.2015.1693 - DOI - PubMed
-
- Gao P, Wang T, Wang D, Liebeskind DS, Shi H, Li T, et al. . Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial. JAMA. (2022) 328:534–42. doi: 10.1001/jama.2022.12000, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous